New Treatment Option for Parkinson Disease
Dr. Jeff Ratliff talks about the FDA approval of Crexont for the treatment of Parkinson disease. Show reference: https://jamanetwork.com/journals/jamaneurology/fullarticle/2808496
28 Elo 20242min
Chronic Adaptive Deep Brain Stimulation Versus Conventional Stimulation in Parkinson Disease
Dr. Jeff Ratliff discusses an exciting study in the world of deep brain stimulation for Parkinson disease. Show reference: https://www.nature.com/articles/s41591-024-03196-z
27 Elo 20243min
Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse
Dr. Tesha Monteith talks about the efficacy of atogepant for the preventive treatment of chronic migraine in participants with and without acute medication overuse. Show reference: https://www.neurolo...
26 Elo 20242min
Neuropsychological Profiles of Deployment-Related mTBI
Dr. Stacey Clardy and Dr. Nicola de Souza discuss how to improve care in the clinic for these veterans and military service members. Show reference: https://www.neurology.org/doi/10.1212/WNL.000000000...
23 Elo 20243min
Long-Term Dementia Risk in Parkinson Disease - Part 1
In the first installment of this two-part series, Dr. Jeff Ratliff and Dr. Daniel Weintraub discuss the risks associated with the development of dementia in patients diagnosed with Parkinson disease. ...
22 Elo 20242min
Interpreting DAT Imaging Results in the Clinical Context - Part 2
In part two of this two-part series, Dr. Jeff Ratliff and Dr. Eduardo De Pablo-Fernández discuss why clinicians should be cautious when relying too much on dopaminergic imaging. Show reference: https:...
21 Elo 20242min
Understanding Long COVID - Part 2
In part two of this two-part series, Dr. Tesha Monteith discusses the key features of long COVID. Show reference: https://doi.org/10.17226/27768
20 Elo 20241min
Understanding Long COVID - Part 1
In part one of this two-part series, Dr. Tesha Monteith discusses the 2024 National Academies of Sciences, Engineering, and Medicine formal definition of long COVID. Show reference: https://doi.org/1...
19 Elo 20241min
